FIGURE 3.
(A) Median percent reduction by focal seizure subtypes (n = 240) and (B) responder rates by focal seizure subtypes during the entire maintenance phase among all patients (maintenance population, n = 214). The median treatment duration for all patients in the maintenance population was 29.5 months